Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Merrimack (Nasdaq: MACK) today announced that it will present research on several of its therapeutic candidates at the 2015 AACR-NCI-EORTC...
Merrimack (Nasdaq: MACK) today announced that the company will host its Third Quarter 2015 Investor Conference Call and webcast at 4:30 p.m., Eastern ...
Merrimack (NASDAQ: MACK), a biopharmaceutical company that applies systems biology to develop cancer treatments and diagnostics, today announced the...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.